Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

Clinical trial NCT01678781 · COMPLETED

Trial details

NCT number: NCT01678781
Sponsor: Abbott
Status: COMPLETED
Study type: OBSERVATIONAL

Irritable Bowel Syndrome

Start date: 2012-07-01
Primary completion: 2013-08-01
Enrollment: 607

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.